Plukenetia volubilis leaves as source of anti-Helicobacter pylori agents
These findings highlight that <i>P. volubilis</i> and astragalin produce a bacteriostatic activity against <i>H. pylori</i> and may have potential to be used in treatment against <i>H. pylori</i>, after further research.
Authors
- Wirginia Anna Kukula-Koch (ORCID: https://orcid.org/0000-0001-7076-600X)
- Sinéad M. Smith (ORCID: https://orcid.org/0000-0003-3460-3590)
- Nathalia Maíra Cabral de Medeiros (ORCID: https://orcid.org/0000-0003-1227-4116)
- Fábio Boylan (ORCID: https://orcid.org/0000-0001-5531-1787)
- Aditya Tan (ORCID: https://orcid.org/0000-0001-6179-2302)
- Kátia Castanho Scortecci (ORCID: https://orcid.org/0000-0002-4690-2785)
- Thomas Bütler (ORCID: https://orcid.org/0000-0003-3180-9868)
Institutions
- Medical University of Lublin (PL)
- Universidade Estadual da Paraíba (BR)
- Trinity College Dublin (IE)
- Universidade Federal do Rio Grande do Norte (BR)
- Medicina (PL)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3389/fphar.2024.1461447
- Citations
- 12
- Primary Topic
- Microbial Metabolites in Food Biotechnology
- Type
- article
- Field-Weighted Citation Impact
- 3.72
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico